Improvement of disseminated lymphangiomatosis with recombinant interferon therapy

Pediatric Pulmonology

Volumn 29, Issue 4, 2000, Pages 321-324

  Laverdière, Caroline ^a   David, Michèle ^a   Dubois, Josée ^b   Russo, Pierre ^b   Hershon, Linda ^a   Lapierre, Jean Guy ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Child; Interferon; Lymphangiomatosis; Lymphanglectasis; Treatment

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ARTICLE; BONE BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFICACY; FOLLOW UP; HUMAN; LUNG BIOPSY; LYMPHANGIECTASIS; LYMPHANGIOMATOSIS; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; HUMANS; INTERFERON ALFA-2B; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034064967     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(200004)29:4<321::AID-PPUL13>3.0.CO;2-C     Document Type: Article

References (20)

1. Hilliard RI, McKendry JBJ, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 1990;86:988-994.
2. Ramani P, Shah A. Lymphangiomatosis: histologic and immunohistochemical analysis of four cases. Am J Surg Pathol 1993;17: 329-335.
3. Shah AR, Dinwiddie R, Woolf D, Ramani R, Higgins JNP, Matthew DJ. Generalized lymphangiomatosis and chylothorax in the pediatric age group. Pediatr Pulmonol 1992;14:126-130.
4. Folkman J. Successful treatment of an angiogenic disease. N Engl J Med 1989;320:1211-1212.
5. Tilg H. New insights into the mechanisms of Interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997;112:1017-1021.
6. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463.
7. Orchard PJ, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro R. Treatment of haemangioendotheliomas with alfa interferon. Lancet 1989;2:565-567.
8. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 1991;118:59-66.
9. Chang E, Boyd A, Nelson CC, Crowley D, Law T, Keough KM, Folkman J, Ezekowitz RAB, Castle VP. Successful treatment of infantile hemangiomas with interferon-α-2b. J Pediatr Hematol Oncol 1997;19:237-244.
10. Tazelaar HD, Kerr D, Yousem SA, Saldana MJ, Langston C, Colby TV. Diffuse pulmonary lymphangiomatosis. Hum Pathol 1993;24:1313-1322.
11. Margraf LR. Case 5: thoracic lymphangiomatosis. Pediatr Pathol Lab Med 1996;16:155-160.
12. Moerman P, Van Geet C, Devlieger H. Lymphangiomatosis of the body wall: a report of two cases associated with chylothorax and fatal outcome. Pediatr Pathol Lab Med 1997;17:617-624.
13. Reinhardt MA, Nelson SC, Sencer SF, Bostrom BC, Kurachek SC, Nesbit ME. Treatment of childhood lymphangiomas with interferon-α. J Pediatr Hematol Oncol 1997;19:232-236.
14. Patton DF, Kaye R, Dickman P, Blatt J. Partial splenic embolization for treatment of disseminated intravascular coagulation in lymphangiomatosis. J Pediatr 1998;132:1057-1060.
15. Barlow C, Priebe CJ, Mulliken JB, Barnes P. Neurotoxicity in the treatment of hemangiomas with interferon alpha-2A. Tenth International Workshop on Vascular Anomalies, Rome, June 1996.
16. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, Ezekowitz RAB. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-530.
17. Enzinger FM, Weiss SW. Tumors of lymph vessels. In: Soft tissue tumors. 3rd ed. St. Louis: C.V. Mosby: 1995. p 679-700.
18. Noonan JA, Walters LR, Reeves JT. Congenital pulmonary lymphangiectasis. Am J Dis Child 1970;120:314-319.
19. Dajee H, Woodhouse R. Lymphangiomatosis of the mediastinum with chylothorax and chylopericardiurn: role of radiation treatment. J Thorac Cardiovasc Surg 1994;108:594.
20. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989;320:1197-1200.